Middle East And Africa Muscle Stimulation Devices Market

Middle East & Africa Muscle Stimulation Devices Market Size & Growth (2023 to 2028)

According to the report, the Size of the Muscle Stimulation Devices Market in the Middle East & Africa is valued at USD 26.03 Million in 2023 and is projected to reach USD 32.29 Million by 2028, to grow at a CAGR of 4.40% during the forecast period 2023 to 2028.

The growing adoption of combination therapy using muscle stimulation devices and physiotherapy will help the MEA muscle stimulation devices market in the coming years. In addition, there is growing demand from physiotherapists for muscle stimulators for patients with spinal multiple sclerosis or stroke or upper limb strengthening and lower limb muscle rehabilitation in stroke patients to help them train for walking. Moreover, sports professionals' rapid adoption of electrical muscle stimulation devices for warm-up sessions in gyms and gymnasiums to prevent muscle soreness during vigorous exercise will help the market grow.

Muscle stimulation devices aid as long-term home therapy to treat paralyzed or Bell's palsy patients to strengthen their muscles or for patients with sciatica as well as cervical and lumbar osteoarthritis, as these modalities help relieve pain without any side effects.

A rapid increase in the geriatric population, more prone to chronic diseases, surgeries, accidents, and neurological diseases, will drive the market. In addition, muscle stimulation has long been used to treat chronic joint pain associated with osteoarthritis, and the growing number of patients will help the market growth. 

Such neuro-muscular conditions are becoming very common in young adults due to obesity, heredity, Vitamin-D deficiency, and athleticism, increasing the demand for additional treatment modalities in the form of muscle stimulation devices during the prognostic period.

Rising muscle stimulation device prices and strict government regulatory policies are estimated to hamper the MEA muscle stimulation devices market growth, especially in emerging economies. Moreover, muscle stimulation devices should be used under the supervision of specialists to avoid the risk of dizziness, injury, or aggravation of the skin; this may be a challenge for the market's growth.

This research report on the Middle East & Africa Muscle Stimulation Devices Market has been segmented and sub-segmented into the following categories.

By Product Type:

• Burst mode alternating current (BMAC)
• Interferential (IF)
• Transcutaneous electrical nerve stimulator (TENS)
• Neuromuscular electric stimulation (NMES)

By Application:

• Musculoskeletal disorder management
• Pain management
• Neurological
• Movement disorder management

By End User:

• Physiotherapy clinics
• Homecare
• Hospitals
• Sports clinics

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the MEA Muscle Stimulation Devices Market is expected to hold the largest market share globally during the forecast period because of many established medical infrastructure and medical device companies driving the regional market.

The UAE Muscle Stimulation Devices Market is projected to witness a decent CAGR due to chronic pain, muscle injuries, and other rapidly growing elderly populations over the forecasted period.

The Saudi Arabia Muscle Stimulation Devices Market is predicted to grow significantly owing to the growing demand for muscle stimulators in-home care settings, government investments in healthcare, and easy availability of the latest technologies will generate significant revenue for the market players in this region.

The South African Muscle Stimulation Devices Market is a lucrative market due to improving healthcare infrastructure. Also, the lenient rules and regulations established by the regulatory bodies in these regions are expected to boost the market.

KEY MARKET PLAYERS

Key Market Companies leading the Middle East & Africa Muscle Stimulation Devices Market Profiled in the Report are DJO Global, Inc., RS Medical, Inc, Omron Corp., Zynex, Inc., NeuroMetrix, Inc.,